ÂÜÀòÂÒÂ×

Sabine Leclercq is the Senior Vice President of Global Technical R&D at GSK Vaccines, where they lead a team of over 1,000 people in all CMC development activities for vaccines from phase I to launch. Previously, Sabine held leadership roles at GSK, including VP of Quality for R&D and VP of Technical R&D, overseeing the development and manufacturing of preclinical and clinical vaccines. Their earlier experience includes positions at UCB Pharma and Baxter International, focusing on analytical development and the establishment of global strategies. Sabine earned a PhD in Chemistry from Université libre de Bruxelles, where they also completed their FNRS research studies.